GUELPH, Ontario, Dec. 18, 2012 (GLOBE NEWSWIRE) -- LifeLearn, Inc. announced today that Bruce Andrews, founder and principal of 101 Investment Corporation, has been elected to the role of Chairman of LifeLearn's board of directors. Andrews has served as a member of LifeLearn's board since 1995 and brings more than 30 years of experience in the animal health industry and a special focus on finance and investments to LifeLearn's board.
"Bruce's experience will be a tremendous asset to LifeLearn as we continue to execute our growth strategies in the animal and human health industries," said Mark Stephenson, president of LifeLearn.
During his career, Andrews served as president of the animal health divisions of Cyanamid and Alpharma, where he was involved with numerous acquisitions and divestitures. He has also served as a consultant to large investment companies such as Oakhill Capital and Texas Pacific Group, as well as on the boards of Agdata and MariCal.
"I look forward to leading the Company to continued significant growth over the next few years," Andrews said.
Andrews replaces R. C. (Chas) Povey, BVSc, PhD, FRCVS, who has stepped down as Chairman after 11 years but remains a member of the board. "We are grateful for Dr. Povey's service as Chairman and look forward to his continuing as a valued member of the board," Stephenson said.
About LifeLearn
LifeLearn, Inc. is an education and communication company that delivers innovative solutions to the veterinary and human health fields through the application of modern technology. The company's vision is to enrich the health and welfare of humans and animals around the world through communication, education and collaboration. LifeLearn was founded in 1994 and evolved from the Continuing Education program at the Ontario Veterinary College, University of Guelph. Today, LifeLearn is a privately held company with headquarters in Guelph, Ontario. To learn more, visit www.LifeLearn.com or www.facebook.com/LifeLearnInc.
The LifeLearn, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13673